Building an AHK-Cu protocol: practical implementation Translating research knowledge into daily practice requires specific decisions about products, timing, and integration with other treatments
JAMA / New England Journal of Medicine (2010) 2
Current medical evidence shows that individuals with normal B12 levels are unlikely to experience increased energy or reduced fatigue from extra B12 supplementation, as the body simply excretes what it does not need
As of 2025, AOD-9604 should be regarded as a discontinued research peptide, not a therapeutic agent , with ongoing relevance confined to academic and mechanistic exploration
Many clients experience increased stamina and mental clarity within days
Medical supervision requirement: All AOD-9604 therapy requires comprehensive physician oversight including baseline health assessment and laboratory work, informed consent regarding research-purposes-only status, regular monitoring of body composition and metabolic markers, dose adjustments based on individual response, and integration with comprehensive health optimization strategies